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a b s t r a c t
We report a case of subcutaneous infection in a 67 year-old Cambodian man who presented with a
5-month history of swelling of the right foot. Histopathology was compatible with phaeohyphomycosis
and the hyphomycete Phialemoniopsis ocularis was identiﬁed by the means of morphological and
molecular techniques. The patient responded well to a 6-month oral treatment with voriconazole alone.
& 2014 The Authors. International Society for Human and Animal Mycology. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Phaeohyphomycoses are fungal infections deﬁned by the presence
of pigmented ﬁlaments in tissues [1,2]. The clinical presentations
of phaeohyphomycosis are mostly superﬁcial, like subcutaneous
abscesses or nodules which usually follow a trauma or skin injury [3].
The number of reported phaeohyphomycosis seems to be in
increasing over the past decades. According to the published cases,
the species involved are diverse, although they mostly belong to
the genera Exophiala, Alternaria, Phialophora, Curvularia and Fon-
secaea [1]. However, new species have been more recently
described [4]: we report here a rare case of a chronic subcutaneous
phaeohyphomycosis of the right foot caused by Phialemoniopsis
ocularis, formerly known as Sarcopodium oculorum. Since
this species is often confused with Phialemonium or Lecythophora
species [4], we used phenotypic characteristics and nucleic
acid sequences for its deﬁnite identiﬁcation [4,5]. The clinical
outcome was satisfactory after a 6-month treatment with oral
voriconazole alone.
2. Case
A 67 year-old Cambodian man, living in France for a little over a
year, presented with a ﬁve month-history of a subcutaneous mass
on the outer face of his right ﬁrst toe (day 0 being the day of
hospital admission). In his medical history, the existence of a non-
insulin dependent diabetes and asymptomatic chronic infection
with hepatitis B virus (HBV) were recorded. There was no known
immunodeﬁciency, and the patient did not remember any trauma.
The clinical examination revealed a large painless swelling of the
ﬁrst metatarsophalangeal joint, mimicking a bursitis as shown
on MRI (Fig. 1). After discussion in multidisciplinary staff, a skin
biopsy was performed on day þ14. The presence of a pus
collection surrounded by a ﬁbrous shell led to the prescription of
antibiotic treatment (amoxicillin – clavulanic acid 1 g/125 mg tid).
At day þ15, the histopathological analysis of the skin biopsy
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showed rare pigmented hyphae, with the Hematoxylin and Eosin
staining (H&E). Calcoﬂuor brightener (Uvitex 2B Blues, Ciba-
Geigy) and Grocott-Gomori's methenamine silver (GMS) staining
conﬁrmed the presence of a few septate and dystrophic scattered
ﬁlaments (Fig. 2).
After four days of incubation at 30 1C and 37 1C on Sabouraud
agar supplemented with antibiotics (Sabouraud Dextrose Agar
Slants with Chloramphenicol – BBLs, Becton Dickinson, Le-Pont-
de-Claix, France), the cultures of the skin biopsy showed downy
brown-pigmented colonies. On malt extract agar 2% (MEA Difcos,
Becton Dickinson, Detroit MI, USA) at 30 1C, colonies were cottony
brown to gray with an uncolored reverse. For identiﬁcation
purposes, the strain was subcultured on oatmeal agar (OA; 30 g
oat ﬂakes, 20 g agar, 1 L distilled water), potato dextrose agar (PDA
Difcos, Becton Dickinson, Detroit MI, USA) and incubated at 25, 30
and 37 1C. The colonies on OA at 25 1C were smooth at the center,
composed mostly by immersed brown mycelia, becoming soft
cottony with abundant aerial sporulation at periphery composed
by evident short stalked conidial heads. On PDA at 25 1C, colonies
were grayish brown, radially folded with sparsely aerial mycelium
(Fig. 3A). Hyphae were initially hyaline smooth-walled, becoming
brown and slightly verrucose. On both media at 30 1C, cultural
characters were similar to those described for 25 1C. The fungus
showed a restricted growth at 37 1C after 21 days. On slide cultures
(OA) (Figs. 3B–G), conidiophores were short, simples or branched
(Figs. 3B–D). Conidia were produced from discrete phialides or
from adelophialides both showing distinctive collarettes (Figs.
3E–F). The production of secondary conidia (repeated phialidic
germination of the conidia) also occurred (Fig. 3G). The discrete
phialides were terminal or lateral and mostly monophialidic, but
polyphialides were also observed: they were cylindrical to ﬂask-
shaped, and adelophialides were cylindrical or reduced to lateral
collarettes on undifferentiated hyphae. Conidia were one-celled,
hyaline to subhyaline, smooth-walled, slightly apiculate at base
Fig. 1. Magnetic Resonance Imaging of the right foot (T1-weighted sequence after Gadolinium-contrast medium injection; (A) in axial plane; (B) in coronal plane). As shown
by the light arrows, a subcutaneous mass was highlighted by a hypersignal in the soft parts next to the outer face of the ﬁrst metatarsophalangeal joint.
Fig. 2. Histological sections of the skin biopsy ((A) H&E staining; (B) GMS staining; (C) Calcoﬂuor ﬂuorescence). The H&E staining showed a few pigmented ramiﬁed hyphae
within necro-inﬂammatory granuloma. The GMS impregnation highlighted scattered dark fungal structures on a green background. The afﬁxing of the skin biopsy prepared
with the brightener showed few blue-ﬂuorescent ﬁlaments with several septa. (For interpretation of references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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and aggregated in slimy heads. Two types of conidia were present:
ellipsoidal to broadly ellipsoidal 5–61.5–2 mm2, and allantoid
with slightly apiculate base 3–51–1.5 mm2. All these character-
istics allowed us to identify the isolate as belonging to the genus
Phialemoniopsis, despite that conidiomata were not observed.
Molecular identiﬁcation was ascertained by PCR ampliﬁcation and
sequencing of the ITS1-5.8S-ITS2 region, the D1-D2 domains of the
ribosomal DNA and two fragments of the actin and tubulin genes [6].
The nucleotide sequence European Nucleotide Archive (ENA) accession
numbers and the percentage of identity for each locus with the type
strain of P. ocularis (IHEM 19077) were HG933293/98.8%, HG933292/
100%, HG933291/98.3% and HG933290/99.2% respectively.
Antifungal susceptibility testing was assessed by broth micro-
dilution EUCAST [7] method with some modiﬁcations. Brieﬂy,
testing of amphotericin B was performed on AM3 medium and
MIC endpoints were determined on an automated microplate
reader spectrophotometer [6,7]. The minimal inhibitory concen-
trations (MICs) for amphotericin B, and echinocandins (caspofun-
gin, micafungin, anidulafungin) were high (8 mg/ml) and much
lower for azoles (voriconazole (0.25 mg/ml), posaconazole (0.5 mg/ml)
and itraconazole (1 mg/ml)).
At day þ43, a treatment with voriconazole (V-Fends, Pﬁzer,
Paris, France) was initiated at a loading dose of 400 mg bid for
24 h, then at 200 mg per os every 12 h. The ﬁrst clinical assessment
after 1.5 month of treatment was satisfactory, except for the dorsal
side of the foot, which was still erythematous (day þ85). Since
drug monitoring previously showed a voriconazole overdosage in
blood at day þ75 (8 mg/L), the dose was divided by two at day
þ85. The antifungal treatment was ﬁnally stopped after 6 months,
at day þ246 (Fig. 4).
Fig. 3. Macro- and microscopical features on lactophenol cotton blue mount of Phialemoniopsis ocularis (CNRMA 12.278) on OA after 21 days of incubation at 251 C
((A) colony on PDA; (B–D) conidiophores, scale bars¼10 mm; (E–F) conidiogenous cells and conidia, scale bars¼5 mm; (G) phialidic production of secondary conidia, scale
bar¼5 mm). The black arrowheads show the conspicuous collarettes, the solid black arrows exhibit the adelophialides. The white arrow points to a discrete phialide and the
red asterisk to a phialide with two conidiogenic loci (polyphialide). (For interpretation of references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
Fig. 4. Aspect of the right foot after 6 months of oral antifungal treatment with
voriconazole. The initial lesion on the outer part of the hallux had almost
disappeared. There was a good healing with no redness or pain. To note, the
mycological exploration of the altered nail was not contributive.
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3. Discussion
Phaeohyphomycoses include all superﬁcial or deep infections
caused by fungi – also named dematiaceous molds – that exhibit a
ﬁlamentous growth within tissues [3,8], regardless of taxonomic
classiﬁcation or anatomical localization of lesions. One must
distinguish them from two other clinical entities: chromoblasto-
mycosis and eumycetoma [2]. Molds responsible for phaeohypho-
mycosis are cosmopolitan, but are mostly prevalent in the warm
and humid climates of (sub-) tropical areas [9]. Although isola-
ted species mainly belong to the genera Exophiala (including
ex-Wangiella), Alternaria, Curvularia, Bipolaris, Exserohilum, Phoma,
Phialemonium, and Phialophora, it is estimated that more than 70
genera and 130 species of dematiaceous fungi may cause phaeo-
hyphomycosis [1]. Cutaneous and subcutaneous phaeohyphomy-
cosis is usually secondary to direct inoculation, most often in the
lower limbs (by trauma or skin penetration by a contaminated
plant thorn/splinter) [1,3]. In a chronic and painless course,
phaeohyphomycosis begins with the appearance of small papules
at the penetration point, and then evolves into a mobile cyst
sometimes ﬁlled with pus. Ultimately, it results in the formation of
nodules in relief or indurated plaques [1,3]. In immunocompro-
mised subjects, phaeohyphomycosis may become opportunistic,
and potentially generates a disseminated or invasive infection that
is associated with a very poor prognosis [4].
The genus Phialemoniopsis has been recently erected to accom-
modate Phialemoniopsis curvata, formerly named Phialemo
nium curvatum which was actually found to be phylogenetically
far away from the type species of the genus Phialemonium, i.e.
P. obovatum [5]. Although it exhibits morphological features
similar to Phialemonium (and also to the genus Lecythophora) such
as the presence of discrete phialides and adelophialides, the most
distinctive character of the Phialemoniopsis species relies in the
formation of picnidial or sporodochial-like conidiomata in culture.
Although our specimen did not produce conidiomata structures in
any agar media tested, groups of short and profusely branched
conidiophores were observed on OA, which were similar to those
forming in sporodochia. The loss of the ability to form conidio-
mata, and the production of the intermediate forms, was also
noticed by Perdomo et al. [4,5]. Besides, the genus Phialemoniopsis
can be also differentiated from Phialemonium by the presence of
conspicuous collarettes in the conidiogenous cells, and from
Lecythophora because the colonies of the latter are slimy and
usually pink or salmon colored. Furthermore, the analysis of the
ITS, 28S region sequences and the D1/D2 domains of the ribosomal
DNA, and two fragments of the actin and tubulin genes allowed
us a reliable identiﬁcation of the strain as P. ocularis, previously
known as S. oculorum [4,5].
In addition to P. curvata and P. ocularis, the genus Phialemo-
niopsis also encompasses the species P. cornearis and P. plurilocu-
losa which have all been isolated from plants, decaying vegetables,
sewage and water [4,5]. Among the twenties human infections
due to the genus Phialemoniopsis, the most were caused by the
P. curvata species [4,5]. They corresponded to localized forms, and
to deep or disseminated mycoses like arthritis and fungemia
respectively [4,10–14]. To our knowledge, only one case of phaeo-
hyphomycosis due to the species P. ocularis was correctly reported
in the literature, since Guarro et al. described a corneal ulcer that
occurred in a Brazilian boy [15]. The few other cases were retro-
spectively documented in collection by the means of ampliﬁcation
of the ITS, D1/D2, actin and β-tubulin sequences. These strains had
been actually isolated in USA from peritoneal dialysis, left hand
sampling and cellulitis aspirate, and formerly identiﬁed erro-
neously as Phialemonium sp. [5].
Few recommendations are available about the treatment of
phaeohyphomycosis. Some case series have highlighted the interest
of total excision of the lesion, especially when it is single and easily
accessible [2,16]. In this speciﬁc context, the antifungal drug does
not therefore seem essential. In case of incomplete resection or
relapse, an adjunctive antifungal medication is thereafter indicated
[2]: thus, oral itraconazole is still considered as the standard
treatment [1,17]. Besides, some authors attempted its association
with terbinaﬁne in Fonsecaea monophora infections, which likely
resulted in a synergistic effect [18]. Likewise, intravenous ampho-
tericin B was experienced before an oral relay with a triazole [19].
As demonstrated by our case, voriconazole nowadays appears to be
a credible alternative for the management of phaeohyphomycosis
[20]. Nevertheless, it is of course difﬁcult to propose an optimal
standard treatment for infections due to Phialemoniopsis spp.,
because of the lack of clinical data. The choice of the antifungal
drug should be always based on the MICs assessed in vitro.
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